Products Platforms Companies News Contact

Vendor source

Reviewed 29 Sept 2026

Completeness Strong (69%)

Jazz

FDA

Jazz is software for the digitalization of radiological findings, with quantitative single lesion tracking. Jazz is aimed at improving the assessment of the evolution of complex brain pathologies such as chronic multiple sclerosis or multi-metastatic brain disease.

Supported by 3 papers

Key Features

Brain lesion detection
Volume quantification

General Information

Product name

Jazz

Company

AI Medical

Modality

Main task

Not specified

Subspeciality

Neuro

Disease targeted

Multiple sclerosis (MS), brain metastasis

Regulatory Information

CE Certification

Pathway:

MDR

Class:

Class IIa

Verified by Health AI Register

FDA Certification

Pathway:

510(k) cleared

Class:

Class II

Verified by Health AI Register

Other certifications

Not specified

Evidence & Research

Peer-Reviewed Papers

3D interactive radiology reports: referring physicians’ acceptance of artificial intelligence varies across practice settings

Neurological Research · Aug 2026

Evaluation of two AI techniques for the detection of new T2/FLAIR lesions in the follow-up of multiple sclerosis patients

Frontiers in Neurology · Oct 2025

Evaluation of the quality and the productivity of neuroradiological reading of multiple sclerosis follow-up MRI scans using an intelligent automation software

Neuroradiology · Jan 2024

Technical Papers

Improved Detection, Description and Efficiency of Multiple Sclerosis Neuroradiological Lesions’ Assessment using a Semi-Automatic Dedicated Deep-Learning Based Software Jazz

Technical Specifications

Patient population age

Not specified

Input

Any brain MRI

Input format

DICOM

Output

Report with user prefered items such as evolution, anatomical position, mcDonald criteria (for MS), lesion treatment (for metastasis), etc

Output format

DICOM, Pdf, Rtf

Integration

Integration CIS (Clinical Information System), Integration in standard reading environment (PACS), Integration RIS (Radiological Information System)

Deployment

Locally on dedicated hardware

Trigger for analysis

Automatically, right after the image acquisition

Processing time

< 10 seconds

Population

Patients with known diagnosis of multiple sclerosis or brain metastasis

Market Presence

On market since

02-2023

AI Platforms

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Subscription

Based on

Not specified

Source: Vendor | First published: Mar 24, 2024 | Last updated: Sep 29, 2026